TY - JOUR
T1 - Managing allergic rhinitis in the pharmacy
T2 - an ARIA guide for implementation in practice
AU - Lourenço, Olga
AU - Bosnic-Anticevich, Sinthia
AU - Costa, Elísio
AU - Fonseca, João A.
AU - Menditto, Enrica
AU - Cvetkovski, Biljana
AU - Kritikos, Vicky
AU - Tan, Rachel
AU - Bedbrook, Anna
AU - Scheire, Sophie
AU - Bachert, Claus
AU - Białek, Sławomir
AU - Briedis, Vitalis
AU - Boussery, Koen
AU - Canonica, G. Walter
AU - Haahtela, Tari
AU - Kuna, Piotr
AU - Novellino, Ettore
AU - Samoliński, Bolesław
AU - Schünemann, Holger J.
AU - Wallace, Dana
AU - Bousquet, Jean
N1 - Copyright the Author(s) 2020. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.
PY - 2020/5/16
Y1 - 2020/5/16
N2 - The paradigm of how we manage allergic rhinitis is shifting with a growing understanding that it is a complex process, requiring a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians. Community pharmacists are the most accessible healthcare professionals to the public and allergic rhinitis is one of the most common diseases managed by pharmacists. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines developed over the past 20 years have improved the care of allergic rhinitis patients through an evidence-based, integrated care approach. In this paper, we propose an integrated approach to allergic rhinitis management in community pharmacy following the 2019 ARIA in the pharmacy guidelines.
AB - The paradigm of how we manage allergic rhinitis is shifting with a growing understanding that it is a complex process, requiring a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians. Community pharmacists are the most accessible healthcare professionals to the public and allergic rhinitis is one of the most common diseases managed by pharmacists. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines developed over the past 20 years have improved the care of allergic rhinitis patients through an evidence-based, integrated care approach. In this paper, we propose an integrated approach to allergic rhinitis management in community pharmacy following the 2019 ARIA in the pharmacy guidelines.
KW - allergic rhinitis
KW - community pharmacy
KW - pharmacist
U2 - 10.3390/pharmacy8020085
DO - 10.3390/pharmacy8020085
M3 - Article
C2 - 32429362
SN - 2226-4787
VL - 8
SP - 1
EP - 14
JO - Pharmacy
JF - Pharmacy
IS - 2
M1 - 85
ER -